Rev Bras Oftalmol.2009;68(6):355-358

Topical immunotherapy for the treatment of periocular basal cell carcinoma

Erick Marcet Santiago de
Macedo
, Rachel Camargo
Carneiro
, Suzana
Matayoshi

DOI: 10.1590/S0034-72802009000600007

The authors describe a patient with a medial canthal nodular basal cell carcinoma treated with Imiquimod 5% cream. Pathologic evaluation of an incisional biopsy performed 12 weeks after treatment revealed complete resolution of local disease. Although the treatment of choice continues to be surgery, topical immunotherapy with imiquimod 5% cream is an emerging therapeutic option suitable for the outpatient treatment of periocular basal cell carcinoma.

Topical immunotherapy for the treatment of periocular basal cell carcinoma

Keywords: ; ; ; ; ;

Comments (0)